Anti-MAGEH1 Polyclonal Antibody for WB, ELISA - Q9H213

Core Product Specifications and Parameters

Biological Background: MAGEH1 Function and Localization

• MAGEH1 (melanoma-associated antigen H1) is also known as apoptosis-related protein 1 (APR-1), MAGE-H1 antigen, and Restin. The gene is MAGEH1 (APR1) in human.
• It belongs to the melanoma-associated antigen (MAGE) family, which are typically classified as tumor antigens.
• UniProt keywords: Phosphoprotein, indicating phosphorylation modification; Proteomics identification; Reference proteome; and Tumor antigen.
• The predicted molecular weight is ~24.4 kDa (UniProt: 24441 Da). The immunogen covers the N-terminal region (aa 10-90 of NP_054780.2).
• The alias APR-1 suggests a potential role in apoptosis, but no specific FUNCTION subsection is provided in the curated UniProt record.
• Similarly, SUBCELLULAR LOCATION is not annotated in the current Swiss-Prot entry, so localization details are unavailable.

Experimental Guidance and Technical Tips

• The immunogen is an N-terminal recombinant fragment (aa 10-90). Consider that this polyclonal antibody may recognize multiple isoforms sharing this region.
• For Western blotting, the predicted band is ~24 kDa; use appropriate gel concentration and molecular weight markers.
• Cross-reactivity with mouse has been noted; validate reactivity in your specific mouse model or sample type.
• In ELISA, the recombinant immunogen protein can serve as a positive control to assess antibody binding.
• As with any polyclonal antibody, lot-to-lot consistency should be verified for quantitative applications.

CamelBio: Your One-Stop Sourcing Bridge

CamelBio provides diagnostic manufacturers, laboratories, and research institutes with one-stop access to IVD raw materials, technical services, and consulting—covering every stage from concept to clinic. This MAGEH1 polyclonal antibody supports research into tumor antigens and apoptosis-related pathways. Our comprehensive supply capabilities encompass validated antibody pairs, optimized monoclonal and polyclonal antibodies, bulk ancillary reagents, and sourcing of rare target raw materials to empower your assay development and commercialization.